EP. 2: Jason Luke, MD: The Association Between Durable Response and Low Disease BurdenAugust 17th 2016
EP. 3: Jason Luke, MD: The Role of LDH, Age, and Sites of Disease in Durability of ResponseAugust 17th 2016
EP. 4: Jason Luke, MD: Predicting Which Patients Will Experience Durable Responses to Targeted TherapyAugust 17th 2016
EP. 6: Jeffrey Weber, MD, PhD: The Role of LDH, Age, and Sites of Disease in Durability of ResponseAugust 17th 2016
EP. 7: Jeffrey Weber, MD, PhD: Predicting Which Patients Will Experience Durable Responses to Targeted TherapyAugust 17th 2016
EP. 8: Jeffrey Weber, MD, PhD: The Association Between Durable Response and Low Disease BurdenAugust 17th 2016
